Synergistic effect of immunotherapy and radiotherapy in non-small cell lung cancer: current clinical trials and prospective challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergistic effect of immunotherapy and radiotherapy in non-small cell lung cancer: current clinical trials and prospective challenges

Published:2019-03-01 Issue:1 Volume:2 Page:57-70
ISSN:2516-1571
Container-title:Precision Clinical Medicine
language:en
Short-container-title:

Author:

Yang Hui¹^ORCID,Jin Tao²,Li Mengqian¹,Xue Jianxin¹,Lu Bo³

Affiliation:

1. Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

2. Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, China

3. Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA

Funder

National Natural Science Foundation of China

Sichuan Provincial Research Foundation

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/pcm/article-pdf/2/1/57/28220278/pbz004.pdf

Reference126 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

3. Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer;Chang;Cancer,2013

4. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

5. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study;Bradley;Lancet Oncol,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant low-dose radiotherapy plus durvalumab and chemotherapy for potentially resectable stage III NSCLC: A phase Ib dose-escalation study;Radiotherapy and Oncology;2024-07

2. The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review;Frontiers in Immunology;2024-05-15

3. Predicting efficacy assessment of combined treatment of radiotherapy and nivolumab for NSCLC patients through virtual clinical trials using QSP modeling;Journal of Pharmacokinetics and Pharmacodynamics;2024-03-17

4. Low‐dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives;International Journal of Cancer;2023-12-07

5. Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients;Clinical Cancer Research;2023-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3